X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs ELDER PHARMA - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD ELDER PHARMA ALEMBIC LTD/
ELDER PHARMA
 
P/E (TTM) x 60.2 -0.2 - View Chart
P/BV x 3.4 0.1 3,364.7% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 ALEMBIC LTD   ELDER PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
ELDER PHARMA
Jun-14
ALEMBIC LTD/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs53380 13.9%   
Low Rs29188 15.6%   
Sales per share (Unadj.) Rs4.7491.2 1.0%  
Earnings per share (Unadj.) Rs8.8-3.2 -275.8%  
Cash flow per share (Unadj.) Rs9.014.4 62.5%  
Dividends per share (Unadj.) Rs0.150-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs27.7376.5 7.4%  
Shares outstanding (eoy) m267.0320.54 1,300.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.70.6 1,504.3%   
Avg P/E ratio x4.7-89.3 -5.2%  
P/CF ratio (eoy) x4.619.7 23.1%  
Price / Book Value ratio x1.50.8 196.3%  
Dividend payout %1.70-   
Avg Mkt Cap Rs m10,9625,833 187.9%   
No. of employees `000NANA-   
Total wages/salary Rs m2382,179 10.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,26010,089 12.5%  
Other income Rs m264257 102.8%   
Total revenues Rs m1,52410,346 14.7%   
Gross profit Rs m83-792 -10.5%  
Depreciation Rs m61361 17.0%   
Interest Rs m02,756 0.0%   
Profit before tax Rs m285-3,653 -7.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-323,713 -0.9%   
Tax Rs m6125 4.9%   
Profit after tax Rs m2,343-65 -3,585.0%  
Gross profit margin %6.6-7.8 -83.7%  
Effective tax rate %2.1-3.4 -62.5%   
Net profit margin %185.9-0.6 -28,699.0%  
BALANCE SHEET DATA
Current assets Rs m1,6899,240 18.3%   
Current liabilities Rs m4869,998 4.9%   
Net working cap to sales %95.4-7.5 -1,270.6%  
Current ratio x3.50.9 375.8%  
Inventory Days Days21746 468.5%  
Debtors Days Days8160 135.2%  
Net fixed assets Rs m1,62410,124 16.0%   
Share capital Rs m534206 259.6%   
"Free" reserves Rs m5,9605,582 106.8%   
Net worth Rs m7,4047,734 95.7%   
Long term debt Rs m1044,889 2.1%   
Total assets Rs m8,01022,882 35.0%  
Interest coverage x950.7-0.3 -292,251.0%   
Debt to equity ratio x00.6 2.2%  
Sales to assets ratio x0.20.4 35.7%   
Return on assets %29.311.8 248.7%  
Return on equity %31.6-0.8 -3,744.6%  
Return on capital %31.322.3 140.2%  
Exports to sales %2.93.0 96.9%   
Imports to sales %28.90.4 6,755.1%   
Exports (fob) Rs m37307 12.1%   
Imports (cif) Rs m36443 843.8%   
Fx inflow Rs m37307 12.1%   
Fx outflow Rs m365125 291.3%   
Net fx Rs m-328181 -180.8%   
CASH FLOW
From Operations Rs m34611,754 2.9%  
From Investments Rs m-48-561 8.5%  
From Financial Activity Rs m-301-6,762 4.5%  
Net Cashflow Rs m-34,432 -0.1%  

Share Holding

Indian Promoters % 64.0 39.6 161.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 7.5 2.7%  
FIIs % 9.7 16.8 57.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 36.1 72.3%  
Shareholders   54,701 16,479 331.9%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   ALKEM LABORATORIES  PLETHICO PHARMA  FDC LTD.  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare ALEMBIC LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Cuts Losses; TCS Up 3%(Closing)

After opening the day in red, share markets in India witnessed volatile trading activity throughout the day but clawed back some gains in the final hours of the trading window.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

Why Bank-Mergers Continue to Remain a Bad Idea(Vivek Kaul's Diary)

Jun 5, 2018

A newsreport suggests that the government plans to merge four public sector banks. We think it's a bad idea.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Jun 15, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS